Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0001209191-16-088713

Director gave up 5,639 shares (to pay taxes)

  • Director acquired 26,661 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
CANNON JAMES ANTHONY Director 2015-12-31 Shares withheld for taxes −1,462 $8.31 $12,149 304,479 D
CANNON JAMES ANTHONY Director 2015-12-31 Shares withheld for taxes −4,177 $8.31 $34,711 300,302 D
CANNON JAMES ANTHONY Director 2015-12-31 Grant or award +26,661 326,963 D
Loading xslF345X03/doc4.xml…